| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
|
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
REGENERON PHARMACEUTICALS, INC. [ REGN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 05/15/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 05/15/2024 | S(1) | 111 | D | $965.69(2) | 886,272 | D | |||
| Common Stock | 05/15/2024 | S(1) | 782 | D | $966.29(3) | 885,490 | D | |||
| Common Stock | 05/15/2024 | S(1) | 1,428 | D | $967.45(4) | 884,062 | D | |||
| Common Stock | 05/15/2024 | S(1) | 3,387 | D | $968.43(5) | 880,675 | D | |||
| Common Stock | 05/15/2024 | S(1) | 1,930 | D | $969.14(6) | 878,745 | D | |||
| Common Stock | 05/15/2024 | S(1) | 846 | D | $970.36(7) | 877,899 | D | |||
| Common Stock | 05/15/2024 | S(1) | 406 | D | $971.28(8) | 877,493 | D | |||
| Common Stock | 05/15/2024 | S(1) | 784 | D | $972.5(9) | 876,709 | D | |||
| Common Stock | 05/15/2024 | S(1) | 1,865 | D | $973.43(10) | 874,844 | D | |||
| Common Stock | 05/15/2024 | S(1) | 4,778 | D | $974.47(11) | 870,066 | D | |||
| Common Stock | 05/15/2024 | S(1) | 5,225 | D | $975.6(12) | 864,841 | D | |||
| Common Stock | 05/15/2024 | S(1) | 6,885 | D | $976.56(13) | 857,956 | D | |||
| Common Stock | 05/15/2024 | S(1) | 9,851 | D | $977.42(14) | 848,105 | D | |||
| Common Stock | 05/15/2024 | S(1) | 4,865 | D | $978.44(15) | 843,240 | D | |||
| Common Stock | 05/15/2024 | S(1) | 504 | D | $979.87(16) | 842,736 | D | |||
| Common Stock | 05/15/2024 | S(1) | 1,223 | D | $980.72(17) | 841,513 | D | |||
| Common Stock | 05/15/2024 | S(1) | 2,283 | D | $981.52(18) | 839,230 | D | |||
| Common Stock | 05/15/2024 | S(1) | 303 | D | $982.29(19) | 838,927 | D | |||
| Common Stock | 05/15/2024 | S(1) | 727 | D | $983.88(20) | 838,200 | D | |||
| Common Stock | 05/15/2024 | S(1) | 53 | D | $984.02 | 838,147 | D | |||
| Common Stock | 05/15/2024 | S(1) | 647 | D | $985.62(21) | 837,500 | D | |||
| Common Stock | 05/15/2024 | S(1) | 442 | D | $986.4(22) | 837,058 | D | |||
| Common Stock | 05/15/2024 | S(1) | 182 | D | $987.38(23) | 836,876 | D | |||
| Common Stock | 05/15/2024 | S(1) | 373 | D | $988.36(24) | 836,503 | D | |||
| Common Stock | 05/15/2024 | S(1) | 120 | D | $989.14(25) | 836,383 | D | |||
| Common Stock | 5,903 | I | By 401(k) Plan | |||||||
| Common Stock | 180,000 | I | By Trust for Chldn.(26) | |||||||
| Common Stock | 158,410 | I | by 2022 GRAT II | |||||||
| Common Stock | 18,148 | I | by Children | |||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024. |
| 2. Represents volume-weighted average price of sales of 111 shares of Company stock on May 15, 2024 at prices ranging from $965.58 to $965.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 3. Represents volume-weighted average price of sales of 782 shares of Company stock on May 15, 2024 at prices ranging from $966.04 to $966.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 4. Represents volume-weighted average price of sales of 1,428 shares of Company stock on May 15, 2024 at prices ranging from $967.07 to $967.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 5. Represents volume-weighted average price of sales of 3,387 shares of Company stock on May 15, 2024 at prices ranging from $968.06 to $968.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 6. Represents volume-weighted average price of sales of 1,930 shares of Company stock on May 15, 2024 at prices ranging from $969.03 to $969.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 7. Represents volume-weighted average price of sales of 846 shares of Company stock on May 15, 2024 at prices ranging from $970.26 to $970.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 8. Represents volume-weighted average price of sales of 406 shares of Company stock on May 15, 2024 at prices ranging from $971.02 to $971.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 9. Represents volume-weighted average price of sales of 784 shares of Company stock on May 15, 2024 at prices ranging from $972.05 to $972.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 10. Represents volume-weighted average price of sales of 1,865 shares of Company stock on May 15, 2024 at prices ranging from $973.00 to $973.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 11. Represents volume-weighted average price of sales of 4,778 shares of Company stock on May 15, 2024 at prices ranging from $974.01 to $974.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 12. Represents volume-weighted average price of sales of 5,225 shares of Company stock on May 15, 2024 at prices ranging from $975.05 to $975.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 13. Represents volume-weighted average price of sales of 6,885 shares of Company stock on May 15, 2024 at prices ranging from $976.00 to $976.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 14. Represents volume-weighted average price of sales of 9,851 shares of Company stock on May 15, 2024 at prices ranging from $977.00 to $977.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 15. Represents volume-weighted average price of sales of 4,865 shares of Company stock on May 15, 2024 at prices ranging from $978.01 to $978.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 16. Represents volume-weighted average price of sales of 504 shares of Company stock on May 15, 2024 at prices ranging from $979.18 to $979.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 17. Represents volume-weighted average price of sales of 1,223 shares of Company stock on May 15, 2024 at prices ranging from $980.11 to $980.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 18. Represents volume-weighted average price of sales of 2,283 shares of Company stock on May 15, 2024 at prices ranging from $981.06 to $981.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 19. Represents volume-weighted average price of sales of 303 shares of Company stock on May 15, 2024 at prices ranging from $982.00 to $982.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 20. Represents volume-weighted average price of sales of 727 shares of Company stock on May 15, 2024 at prices ranging from $983.21 to $983.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 21. Represents volume-weighted average price of sales of 647 shares of Company stock on May 15, 2024 at prices ranging from $985.11 to $985.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 22. Represents volume-weighted average price of sales of 442 shares of Company stock on May 15, 2024 at prices ranging from $986.30 to $986.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 23. Represents volume-weighted average price of sales of 182 shares of Company stock on May 15, 2024 at prices ranging from $987.03 to $987.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 24. Represents volume-weighted average price of sales of 373 shares of Company stock on May 15, 2024 at prices ranging from $988.00 to $988.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 25. Represents volume-weighted average price of sales of 120 shares of Company stock on May 15, 2024 at prices ranging from $989.01 to $989.28. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 26. As investment trustee of trusts for the benefit of the reporting person's children. |
| /s/**George D. Yancopoulos | 05/17/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||